News

NIH/NCATS and InSphero Host Inaugural 3D Tumor Model Standards Working Group at AACR 2017 Establishing standards for next-generation tumor models to benefit drug discovery and

InSphero's 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing Customer and company presentations highlight InSphero

Novel 3D Cell-based Assays Accelerate Discovery for Immuno-oncology/CAR-T Therapies InSphero presents latest data demonstrating immune cell interaction with 3D tumor models for in vitro efficacy testing of oncology drugs and […]

InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing Customer and company presentations highlight InSphero 3D InSight™ Liver Microtissues as [...]

InSphero Launches 3D InSight™ Monkey Liver Microtissues at Annual Society of Toxicology Meeting 3D liver microtissues comprised of cynomolgus hepatocytes provide physiologically relevant in vitro model for investigating species-specific liver […]

InSphero to Introduce GravityTRAP™ 384 Microtissue Platform at SLAS2017 The Global leader in 3D cell culture technology to deliver standardized 3D models in new high-throughput,

InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System Dr. Olivier Frey was honored by IQ Consortium and AAALAC International for work

3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference Event draws over 100 leading government, industry, and academic leaders to further translational

InSphero, US Congressional Leaders Discuss Technologies to Reduce Animal Research US legislators and InSphero experts discuss the benefits of human-derived 3D microtissues for more efficient

InSphero Launches 3D Mitochondrial Toxicity Testing Service New contract screening offering combines advanced 3D liver microtissue models and Agilent XFe96 Analyzer to identify mitochondrial liabilities

Registration Open for New Frontiers in 3D Cell Culture-based Screening Technologies Conference Schlieren, Switzerland, July 13, 2016 – Inaugural meeting, organized by InSphero AG, NCATS,

InvitroCue Commences Pancreatic Toxicity Assay Development 11 July 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, has progressed its technology in modeling multi-organ toxicity

Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development Schlieren, Switzerland, June 16, 2016 – Liver spheroids display longer

InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury Schlieren, Switzerland, March 16, 2016 – 3D human liver microtissues comprised of pooled

InSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual Schlieren, Switzerland, February 10, 2016 – Latest update of industry manual for development of